Dr. Barry Dworkin

ASA trial to study whether it can reduce risk of cancer recurrence

Madely Health Headlines Commentary for October 22, 2015

Source:

Aspirin trial to examine if it can stop cancer returning

 

Related posts:

  1. Study concludes ASA should not be used for primary prevention of heart disease because side effects outweigh benefits
  2. Meta-analysis cannot recommend ASA for primary prevention of heart disease and cancer in otherwise health people 50 years and up for lack of conclusive evvidence
  3. Breast cancer risk from hormone replacement needs perspective when compared to other contributing factors
  4. Multivitamins do little to reduce cancer risk in male physicians over 50:study